Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Blank-controlled, Open Label Study of the Safety and Efficacy of Propranolol in Reducing Stroke Associated Pneumonia and Urinary Tract Infection

NCT05375240 is registered in ClinicalTrials.gov with Tianjin Medical University General Hospital as lead sponsor.

NCT NCT05375240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05375240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Blank-controlled, Open Label Study of the Safety and Efficacy of Propranolol in Reducing Stroke Associated Pneumonia and Urinary Tract Infection
Lead sponsor
Tianjin Medical University General Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2022
Completion date
June 30, 2024
Enrollment
45 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

beta blocker, brain diseases, cardiovascular diseases, central nervous system diseases, cerebrovascular disorders, immunologic factors, ischemic stroke, molecular mechanisms of pharmacological action, nervous system diseases, physiological effects of drugs, propranolol, stroke